Phreesia Class Action Lawsuit Notification
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 1 hour ago
0mins
Source: Globenewswire
- Class Action Notification: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing weakened pharmaceutical marketing commitments in its Network Solutions segment, which led to investor losses when the truth emerged, indicating a slowdown in demand and reduced visibility in key revenue streams.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, consistently ranking in the top four since 2013, and recovering over $438 million for investors in 2019 alone, showcasing its strong track record in this field.
- Investor Advisory: Investors are advised to choose legal counsel carefully; Rosen Law Firm recommends selecting attorneys with proven success in securities class actions to avoid partnering with firms that merely act as intermediaries, ensuring effective protection of their rights.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy PHR?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on PHR
Wall Street analysts forecast PHR stock price to rise
12 Analyst Rating
12 Buy
0 Hold
0 Sell
Strong Buy
Current: 9.150
Low
24.00
Averages
29.09
High
35.00
Current: 9.150
Low
24.00
Averages
29.09
High
35.00
About PHR
Phreesia, Inc. is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations. The Company's solutions include software-as-a-service (SaaS)-based integrated tools that manage patient access, registration, and payments. In addition, its solutions include clinical assessments to screen patients for a variety of physical, behavioral and mental health conditions, helping providers to understand their patients and connect them to needed services, resulting in improved health outcomes. Its Technology solutions segment provides life sciences companies, health plans and other payer organizations (payers), patient advocacy, public interest and other not-for-profit organizations with a channel for direct communication with patients. The Company's solutions also include additional products and services, such as the MediFind provider directory, which helps patients find care based on providers' specific clinical expertise.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Phreesia Class Action Lawsuit Notification
- Class Action Notification: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing weakened pharmaceutical marketing commitments in its Network Solutions segment, which led to investor losses when the truth emerged, indicating a slowdown in demand and reduced visibility in key revenue streams.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, consistently ranking in the top four since 2013, and recovering over $438 million for investors in 2019 alone, showcasing its strong track record in this field.
- Investor Advisory: Investors are advised to choose legal counsel carefully; Rosen Law Firm recommends selecting attorneys with proven success in securities class actions to avoid partnering with firms that merely act as intermediaries, ensuring effective protection of their rights.
See More
Phreesia Shareholder Class Action Notice
- Lawsuit Background: The Gross Law Firm has issued a notice to shareholders of Phreesia, Inc. (NYSE:PHR), encouraging those who purchased shares during the class period from May 8, 2025, to March 30, 2026, to contact the firm regarding potential lead plaintiff appointment.
- Allegations: The complaint alleges that Phreesia misled investors by providing overly positive statements while concealing significant adverse facts about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.
- Financial Impact: On March 30, 2026, Phreesia announced a significant reduction in revenue growth projections for fiscal year 2027, attributing the shortfall to macroeconomic factors and weakened pharmaceutical marketing commitments, resulting in a stock price decline from $11.41 per share on March 30, 2025, to $8.38 per share on March 31, 2026, a drop of approximately 27%.
- Shareholder Next Steps: Shareholders must register for the class action by July 13, 2026, and upon registration, they will receive updates throughout the case lifecycle, with no cost or obligation to participate.
See More
Investors Alert: Class Action Lawsuit Deadlines
- Phreesia Class Action: A class action lawsuit against Phreesia, Inc. alleges misleading statements made between May 8, 2025, and March 30, 2026, impacting investors' long-term growth outlook, with a deadline of July 13, 2026, to apply as lead plaintiff.
- AeroVironment Lawsuit Details: The class action against AeroVironment, Inc. claims failure to disclose material facts regarding the competitive landscape from June 25, 2025, to March 10, 2026, with a lead plaintiff application deadline of July 27, 2026.
- Lucid Group Lawsuit Overview: Lucid Group, Inc. faces a class action lawsuit for misleading statements about manufacturing and delivery capabilities between February 25, 2026, and April 13, 2026, with a deadline of July 28, 2026, for lead plaintiff applications.
- Law Firm Background: Holzer & Holzer, LLC, a top-rated securities litigation firm, has been instrumental in recovering hundreds of millions for shareholders since 2000, highlighting its commitment to investor rights and legal representation.
See More
Phreesia Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
- Class Action Filed: Bragar Eagel & Squire has initiated a class action lawsuit against Phreesia in the U.S. District Court for Delaware on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026, with a deadline of July 13, 2026, to apply as lead plaintiffs.
- Allegations: The lawsuit claims that Phreesia and its executives violated federal securities laws by failing to disclose the true state of slowing demand and reduced visibility in key revenue streams, particularly the weakened pharmaceutical marketing commitments in its Network Solutions segment.
- Revenue Guidance Cut: On March 30, 2026, Phreesia lowered its fiscal 2027 revenue guidance to $510-$520 million, a reduction of $35 million to $49 million from the previous range, resulting in a stock price drop of 21% to 28%.
- Management Misrepresentation: CFO Balaji Gandhi's comments in the December 2025 earnings call about
See More
Investor Class Action Lawsuit Reminder
- Phreesia Lawsuit: Phreesia Inc. faces a class action for misleading investors regarding its long-term growth outlook during the period from May 8, 2025, to March 30, 2026, with a lead plaintiff deadline of July 13, 2026, putting its revenue projections at risk.
- Sportradar Allegations: Sportradar Group AG is accused of collaborating with black-market gambling operators from November 7, 2024, to April 21, 2026, undermining its claims of strict legal compliance, with a lead plaintiff deadline of July 17, 2026.
- Commvault Issues: Commvault Systems Inc. is implicated in misleading statements regarding the impact of sales types on its ARR growth from April 29, 2025, to January 26, 2026, with a lead plaintiff deadline of July 17, 2026, affecting investor confidence.
- Veritone Financial Misstatements: Veritone, Inc. faces scrutiny for inaccurately recording revenue from October 14, 2025, to April 14, 2026, necessitating a restatement of financials, with a lead plaintiff deadline of July 20, 2026, impacting its credibility with investors.
See More
Investor Class Action Lawsuit Reminder
- Phreesia Lawsuit: Phreesia Inc. (NYSE:PHR) is facing allegations for misleading investors during the period from May 8, 2025, to March 30, 2026, by claiming reliable long-term growth prospects while the sustainability of its pharmaceutical marketing commitments was uncertain, putting its 2027 revenue target at risk.
- Sportradar Allegations: Sportradar Group AG (NASDAQ:SRAD) is accused of collaborating with black-market gambling operators to boost revenues from November 7, 2024, to April 21, 2026, despite assurances of legal compliance, leading to materially misleading statements about its business prospects.
- Commvault Misrepresentation: Commvault Systems Inc. (NASDAQ:CVLT) is under scrutiny for failing to disclose the impact of sales types on annual recurring revenue (ARR) growth during the period from April 29, 2025, to January 26, 2026, resulting in misleading positive statements about its business outlook.
- Veritone Financial Issues: Veritone, Inc. (NASDAQ:VERI) faces allegations of inaccurately recording revenue and costs from October 14, 2025, to April 14, 2026, necessitating a restatement of financial statements, with its optimistic business outlook deemed materially misleading.
See More
Phreesia Class Action Lawsuit Notification
- Class Action Notification: Rosen Law Firm reminds investors who purchased Phreesia (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, to apply as lead plaintiffs by July 13, 2026, to potentially receive compensation without any out-of-pocket costs.
- Lawsuit Background: The lawsuit alleges that Phreesia made false or misleading statements during the class period, concealing weakened pharmaceutical marketing commitments in its Network Solutions segment, which led to investor losses when the truth emerged, indicating a slowdown in demand and reduced visibility in key revenue streams.
- Law Firm Credentials: Rosen Law Firm specializes in securities class actions and was ranked No. 1 by ISS Securities Class Action Services in 2017, consistently ranking in the top four since 2013, and recovering over $438 million for investors in 2019 alone, showcasing its strong track record in this field.
- Investor Advisory: Investors are advised to choose legal counsel carefully; Rosen Law Firm recommends selecting attorneys with proven success in securities class actions to avoid partnering with firms that merely act as intermediaries, ensuring effective protection of their rights.
See More
Phreesia Shareholder Class Action Notice
- Lawsuit Background: The Gross Law Firm has issued a notice to shareholders of Phreesia, Inc. (NYSE:PHR), encouraging those who purchased shares during the class period from May 8, 2025, to March 30, 2026, to contact the firm regarding potential lead plaintiff appointment.
- Allegations: The complaint alleges that Phreesia misled investors by providing overly positive statements while concealing significant adverse facts about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment.
- Financial Impact: On March 30, 2026, Phreesia announced a significant reduction in revenue growth projections for fiscal year 2027, attributing the shortfall to macroeconomic factors and weakened pharmaceutical marketing commitments, resulting in a stock price decline from $11.41 per share on March 30, 2025, to $8.38 per share on March 31, 2026, a drop of approximately 27%.
- Shareholder Next Steps: Shareholders must register for the class action by July 13, 2026, and upon registration, they will receive updates throughout the case lifecycle, with no cost or obligation to participate.
See More
Investors Alert: Class Action Lawsuit Deadlines
- Phreesia Class Action: A class action lawsuit against Phreesia, Inc. alleges misleading statements made between May 8, 2025, and March 30, 2026, impacting investors' long-term growth outlook, with a deadline of July 13, 2026, to apply as lead plaintiff.
- AeroVironment Lawsuit Details: The class action against AeroVironment, Inc. claims failure to disclose material facts regarding the competitive landscape from June 25, 2025, to March 10, 2026, with a lead plaintiff application deadline of July 27, 2026.
- Lucid Group Lawsuit Overview: Lucid Group, Inc. faces a class action lawsuit for misleading statements about manufacturing and delivery capabilities between February 25, 2026, and April 13, 2026, with a deadline of July 28, 2026, for lead plaintiff applications.
- Law Firm Background: Holzer & Holzer, LLC, a top-rated securities litigation firm, has been instrumental in recovering hundreds of millions for shareholders since 2000, highlighting its commitment to investor rights and legal representation.
See More
Phreesia Faces Class Action Lawsuit; Investors Encouraged to Contact Attorneys
- Class Action Filed: Bragar Eagel & Squire has initiated a class action lawsuit against Phreesia in the U.S. District Court for Delaware on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026, with a deadline of July 13, 2026, to apply as lead plaintiffs.
- Allegations: The lawsuit claims that Phreesia and its executives violated federal securities laws by failing to disclose the true state of slowing demand and reduced visibility in key revenue streams, particularly the weakened pharmaceutical marketing commitments in its Network Solutions segment.
- Revenue Guidance Cut: On March 30, 2026, Phreesia lowered its fiscal 2027 revenue guidance to $510-$520 million, a reduction of $35 million to $49 million from the previous range, resulting in a stock price drop of 21% to 28%.
- Management Misrepresentation: CFO Balaji Gandhi's comments in the December 2025 earnings call about
See More
Investor Class Action Lawsuit Reminder
- Phreesia Lawsuit: Phreesia Inc. faces a class action for misleading investors regarding its long-term growth outlook during the period from May 8, 2025, to March 30, 2026, with a lead plaintiff deadline of July 13, 2026, putting its revenue projections at risk.
- Sportradar Allegations: Sportradar Group AG is accused of collaborating with black-market gambling operators from November 7, 2024, to April 21, 2026, undermining its claims of strict legal compliance, with a lead plaintiff deadline of July 17, 2026.
- Commvault Issues: Commvault Systems Inc. is implicated in misleading statements regarding the impact of sales types on its ARR growth from April 29, 2025, to January 26, 2026, with a lead plaintiff deadline of July 17, 2026, affecting investor confidence.
- Veritone Financial Misstatements: Veritone, Inc. faces scrutiny for inaccurately recording revenue from October 14, 2025, to April 14, 2026, necessitating a restatement of financials, with a lead plaintiff deadline of July 20, 2026, impacting its credibility with investors.
See More
Investor Class Action Lawsuit Reminder
- Phreesia Lawsuit: Phreesia Inc. (NYSE:PHR) is facing allegations for misleading investors during the period from May 8, 2025, to March 30, 2026, by claiming reliable long-term growth prospects while the sustainability of its pharmaceutical marketing commitments was uncertain, putting its 2027 revenue target at risk.
- Sportradar Allegations: Sportradar Group AG (NASDAQ:SRAD) is accused of collaborating with black-market gambling operators to boost revenues from November 7, 2024, to April 21, 2026, despite assurances of legal compliance, leading to materially misleading statements about its business prospects.
- Commvault Misrepresentation: Commvault Systems Inc. (NASDAQ:CVLT) is under scrutiny for failing to disclose the impact of sales types on annual recurring revenue (ARR) growth during the period from April 29, 2025, to January 26, 2026, resulting in misleading positive statements about its business outlook.
- Veritone Financial Issues: Veritone, Inc. (NASDAQ:VERI) faces allegations of inaccurately recording revenue and costs from October 14, 2025, to April 14, 2026, necessitating a restatement of financial statements, with its optimistic business outlook deemed materially misleading.
See More
